The Crucial Role of Therapy in Ketamine Treatment: More Than Just the Medicine

Ketamine infusion therapy is an emerging treatment option for individuals suffering from severe, treatment-resistant migraines. Originally developed as an anesthetic, ketamine has shown promise in addressing various chronic pain conditions, including migraines.

This therapy involves the administration of low-dose ketamine through intravenous infusion, typically in a controlled medical setting. The treatment works by targeting NMDA (N-methyl-D-aspartate) receptors in the brain, which are involved in pain signal processing and central sensitization. By modulating these receptors, ketamine may help to disrupt and reset the overactive pain pathways that contribute to chronic migraines.

Ketamine's use for migraine treatment is considered "off-label," meaning it hasn't been officially approved for this specific purpose by regulatory agencies. However, doctors can prescribe it based on their clinical judgment when they believe the potential benefits outweigh the risks for a particular patient.

Early research and anecdotal evidence suggest that some patients experience rapid and significant pain relief following ketamine infusions. Benefits may include:

1. Quick onset of pain reduction
2. Decreased frequency of migraine attacks
3. Longer-lasting relief compared to traditional treatments
4. Improved quality of life and daily functioning

However, it's important to note that ketamine therapy is not without risks. Potential side effects can include dizziness, nausea, dissociation, and in rare cases, more serious complications. Additionally, as a controlled substance, ketamine requires careful monitoring to prevent misuse or abuse.

The treatment protocol for migraine management typically involves a series of infusions over several days or weeks, with maintenance sessions as needed. The exact regimen can vary depending on the healthcare provider and the patient's individual response.

While promising, ketamine infusion therapy for migraines is still in the early stages of research. Larger, controlled studies are needed to fully establish its efficacy, optimal dosing, and long-term safety profile. Furthermore, the cost of treatment can be substantial and is often not covered by insurance due to its off-label status.

Patients considering ketamine therapy for migraines should consult with a healthcare professional to discuss potential benefits, risks, and alternative treatment options. As research in this field progresses, we may gain a clearer understanding of ketamine's role in migraine management and its potential to improve outcomes for those suffering from this debilitating condition.

For more detailed information on ketamine treatments and services, interested individuals can explore resources such as https://ketamine.day, https://ketamineannapolis.com, and https://annapolisesketamine.com. These websites offer insights into ketamine therapy, including its applications, potential benefits, and available treatment options in specific locations like Annapolis.

The inclusion of an episode on "The Ketamine Podcast" featuring Lorraine Nilon, a renowned expert in self-reflection, addiction recovery, and spirituality, holds profound significance for its listeners, particularly those engaged in or considering ketamine-assisted therapy. While ketamine is increasingly acknowledged for its potential in treating conditions like depression, PTSD, and chronic pain, its therapy involves a journey that is as much psychological and emotional as it is medical. The insights offered by Lorraine Nilon are particularly valuable for individuals undergoing this unique form of therapy. Her expertise in exploring the inner self and the soul's journey offers a complementary and enriching perspective to the medical and therapeutic aspects of ketamine treatment.


Ketamine therapy, known for inducing introspective and transformative experiences, often brings patients face-to-face with deep-seated emotions and psychological states. Lorraine's discussion on the importance of confronting and managing these emotions aligns closely with the experiences of those undergoing ketamine therapy. Such therapy can evoke intense emotional responses, including the resurfacing of repressed memories or traumas. Lorraine's guidance on navigating these complex emotional landscapes can provide invaluable tools for patients, helping them to process and integrate these experiences effectively.


Moreover, her focus on overcoming negative self-judgments is particularly relevant. Many individuals seeking ketamine therapy struggle with self-esteem and self-worth issues, often exacerbated by their mental health conditions. Lorraine's insights into how one can work through these negative self-perceptions and develop a more compassionate and understanding relationship with oneself can be incredibly empowering for patients. This self-compassion is a crucial component of the healing process, as it enables individuals to approach their experiences and challenges with more kindness and less judgment.


In addition to the deeper psychological and emotional discussions, the episode also touches upon lighter topics, providing a well-rounded listening experience. Discussions around reconnecting with one’s inner child, for instance, offer a refreshing perspective on healing and personal growth. These conversations emphasize the importance of joy, playfulness, and spontaneity in the healing process, elements that are often overlooked in traditional therapeutic settings. The inclusion of such topics not only makes the podcast more accessible but also highlights the multifaceted nature of healing and recovery.


Furthermore, the personal anecdotes and stories shared by the host, Mark Leeds, add a personal and relatable dimension to the podcast. These stories, drawn from personal experiences, offer listeners real-life examples of how individuals navigate their own paths of healing and discovery. They serve as a reminder that the journey through therapy and recovery is deeply personal and unique to each individual, and there is no one-size-fits-all approach.


Lorraine's expertise also extends to the spiritual dimension of healing, an aspect that is particularly intriguing for many undergoing ketamine therapy. Given that ketamine therapy can sometimes induce experiences that transcend the ordinary boundaries of consciousness, her insights into spirituality and the exploration of the unknown can be particularly resonant. She encourages listeners to develop a personal relationship with these experiences, moving beyond preconceived notions and beliefs to a more experiential understanding of their own spirituality.


The inclusion of discussions around fear, especially the fear of acknowledging and confronting one’s emotions, is another crucial aspect of this episode. Individuals undergoing ketamine therapy often face a multitude of fears, not only related to their mental health conditions but also concerning the therapy itself. Lorraine's guidance on how to approach these fears, understand them, and ultimately work through them can be a source of great comfort and support for listeners.


Finally, Lorraine Nilon's episode on "The Ketamine Podcast" provides not just theoretical insights but also practical advice. Her suggestions on various techniques and approaches for self-reflection and emotional management can be directly applied by listeners in their everyday lives. This practical aspect makes the podcast not only informative but also immensely useful for those seeking to apply these insights in a tangible way.


In conclusion, the episode featuring Lorraine Nilon on "The Ketamine Podcast" offers a comprehensive look into the psychological, emotional, and spiritual aspects of healing, particularly relevant to those involved in ketamine-assisted therapy. By blending deep introspective insights with accessible and relatable content, it provides a valuable resource for anyone on this complex journey of healing and self-discovery. The episode is a testament to the multifaceted nature of recovery and the importance of addressing all aspects of the self – mind, body, and spirit – in the healing process.

Visit Lorraine Nilon here: https://lorrainenilon.com.au/

And please visit Dr. Mark Leeds here: https://drleeds.com and at our podcast website: https://therehab.com

If you are looking for nootropics for creativity, or the best nootropics for motivation, ketamine is not the answer. However, ketamine infusion therapy is useful for treating many mental health conditions and pain syndromes, including depression, anxiety, suicidality, PTSD, OCD, addiction, bipolar, neuropathic pain, migraines, CRPS, fibromyalgia, and chronic lyme disease (PLDTS). Ketamine stimulates the growth of new dendritic connections in the brain, a process known as neurogenesis. Together with psychotherapy, ketamine infusion treatments are highly effective.

In this episode of The Ketamine Podcast, hosted by Mark Leeds, D.O., we present an in-depth conversation with Dr. Ladan Eshkevari, PhD, CRNA, LAc, FAAN, a recognized authority from Avesta Ketamine Wellness. The discourse concentrates on the therapeutic mechanisms of ketamine and its role in neuroregeneration and brain healing.

Dr. Eshkevari will elucidate the complexities of ketamine therapy, discussing its potential therapeutic benefits across a spectrum of conditions. The discussion encompasses ketamine's involvement in pain management, its effects on mood disorders, and its implications for chronic pain patients, individuals grappling with depression and anxiety, and those undergoing extended withdrawal.

The episode will further delve into the intriguing association between ketamine therapy and Lyme disease. We will examine how ketamine, when paired with substances such as magnesium and lidocaine, can offer relief to those persistently afflicted by the disease's symptoms. Additionally, the safety parameters around ketamine administration will be discussed in detail, highlighting its side effects, impact on the respiratory system, and utility as an anesthetic.

A segment of the conversation is dedicated to the interplay between acupuncture and ketamine therapy. Here, Dr. Eshkevari will explain the significance of chi in traditional Chinese medicine and how specific acupuncture points, notably the "4 gates," may amplify the effectiveness of ketamine treatments.

Listeners are encouraged to immerse themselves in this rigorous examination of ketamine therapy and its transformative potential, led by the expertise of Dr. Ladan Eshkevari.

Please visit Dr. Eshkevari at https://avestaketaminewellness.com/.

Also, if you find this material interesting and helpful, please visit our podcast website and practice website here:

https://drleeds.com and https://therehab.com.

With over three decades of expertise in anesthesiology, Dr. Steven Reichbach reappears on the Ketamine Podcast. He delves into the transformative power of ketamine therapy in addressing various mood disorders and persistent neuropathic pain conditions. A special emphasis is placed on the breakthroughs observed with ketamine in treating obsessive-compulsive disorder (OCD), aiding patients in managing their intrusive thoughts and recurrent behaviors. Moreover, Dr. Reichbach sheds light on its broader applications, especially in patients grappling with treatment-resistant depression, anxiety, trauma, and underlying OCD symptoms. The dialogue shifts towards ketamine's potential in addressing suicidality. Highlighted is a poignant case of a patient plagued by chronic pain and suicidal tendencies, who witnessed substantial upliftment in both physical and psychological states post-ketamine intervention. Dive with us into the captivating realm of ketamine therapy and its prospective game-changing impact on mental health care.
Please visit Dr. Reichbach here: https://www.findpainrelief.com/about/steven-reichbach-md

In this episode, we explore the groundbreaking Neuro Direct technology that provides a new way of safely and effectively administering neuroeffective compounds without the side effects usually associated with oral or systemic administration. Dr. Ronald Ongdon invented the technology, and it has been used successfully for sumatryptin, a drug for severe migraines, and shows significant promise for the administration of ketamine for PTSD and depression. We'll learn about a recent observational study that showed an 80% favorable response rate to the neurodirect ketamine in an off-label format and how the cream's effectiveness can be seen immediately, unlike traditional SSRIs that require six weeks to take effect. We'll also discuss the risks associated with receiving treatments that haven't gone through the appropriate pathways, the urgency of effective treatments for mental health issues, and promising developments in clinical trials for the company's product. Additionally, we'll explore how Micro dosing with psychedelics like psilocybin and LSD has been gaining popularity, and how the guest's product may bring some of the benefits of microdosing to the market.

Dr. Steven Radowitz, the Chief Medical Officer and Co-Founder of Nushama, has a wealth of experience seeing the effects of trauma and addiction on physical health. He started his career in New York during the peak of the opioid and AIDS crises, where he worked as the medical director of the inpatient alcohol and opiate detox and treatment unit at St. Vincent’s NYC Midtown medical center. With his team at Nushama, he supports people struggling with substance use by developing treatment modalities that integrate neuroscience, mystical experience, and integration therapy. He believes that current solutions often fall short, treating symptoms without addressing underlying issues, and that psychedelic medicine's framework is the future of mental wellness.
Dr. Radowitz's team offers Ketamine for the Reduction of Alcohol Relapse (KARE), a highly efficacious ketamine-assisted psychotherapy protocol that has been found to be 86% effective. Nushama is the first to bring this revolutionary treatment to New York City, using the power of psychedelics to transform addictive behaviors. He has been a DEA-licensed provider for over a decade, treating opioid addiction with buprenorphine maintenance therapy.
Dr. Radowitz sees the source of disease as a “dis-ease” that results from a misalignment of mind, body, and spirit. He has a passion for preventive medicine, getting to the root of a health problem before it manifests. In contrast to traditional medicine, he views psychedelics as powerful tools to help us become aware of the origin of imbalance and guide us toward wholeness, health, and wellbeing, healing from within. He and the Nushama team have administered thousands of ketamine journeys for mood disorders and are known to be best-in-class and among the most experienced globally.
Before joining Nushama, Dr. Radowitz ran the primary care program at Goldman Sachs for over 10 years and held a private practice specializing in general medicine, HIV care, and preventive medicine. He completed his Bachelor of Science in Anatomy and Cell Biology from McGill University and his medical degree at The Chicago Medical School with an internal medicine residency at Rush University Medical Center. He currently mentors master’s students attending the Columbia School of Social Work interning at Nushama for their field practicum and has also supervised Columbia medical students and residents.


Dr. Radowitz's personal journey towards spirituality began after moving to New York from Montreal. He explored the city’s culture and nightlife on a journey to expand his consciousness and eventually discovered the study of Kabbalah, Jewish mysticism, transcendental meditation, and various forms of yoga. After reading How to Change Your Mind, he witnessed the profound transformation that psychedelics can bring and serendipitously met Co-Founder Jay Godfrey, who invited him to join Nushama.

For more information, please visit my practice website: https://drleeds.com and the podcast website: https://therehab.com